Synlogic, Inc. (SYBX)
NASDAQ: SYBX · Real-Time Price · USD
1.650
-0.020 (-1.20%)
At close: Nov 26, 2025, 4:00 PM EST
1.675
+0.025 (1.52%)
After-hours: Nov 26, 2025, 4:10 PM EST
Synlogic Revenue
In the year 2024, Synlogic had annual revenue of $8.00K, down -99.76%.
Revenue (ttm)
$8.00K
Revenue Growth
-99.76%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
19.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.00K | -3.36M | -99.76% |
| Dec 31, 2023 | 3.37M | 2.19M | 185.68% |
| Dec 31, 2022 | 1.18M | -574.00K | -32.73% |
| Dec 31, 2021 | 1.75M | 1.21M | 221.83% |
| Dec 31, 2020 | 545.00K | -1.68M | -75.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SYBX News
- 1 year ago - Synlogic Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 1 year ago - Synlogic Adopts Limited Duration Stockholders Rights Plan - GlobeNewsWire
- 1 year ago - Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update - GlobeNewsWire
- 1 year ago - Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria - GlobeNewsWire
- 2 years ago - Synlogic Provides Corporate Update and Outlook for 2024 - GlobeNewsWire